Shares of SkinBioTherapeutics plc (LON:SBTX – Get Free Report) shot up 2.9% on Friday . The company traded as high as GBX 9 ($0.11) and last traded at GBX 8.75 ($0.11). 235,810 shares changed hands during mid-day trading, a decline of 64% from the average session volume of 651,189 shares. The stock had previously closed at GBX 8.50 ($0.11).
SkinBioTherapeutics Stock Up 2.9 %
The firm has a market cap of £17.53 million, a price-to-earnings ratio of -437.50 and a beta of 1.67. The firm has a 50 day moving average price of GBX 9.49 and a 200-day moving average price of GBX 11.08. The company has a current ratio of 6.57, a quick ratio of 10.01 and a debt-to-equity ratio of 2.66.
SkinBioTherapeutics Company Profile
SkinBioTherapeutics plc, a life science company, engages in identification and development of technology that harnesses the human microbiome to improve health in the United Kingdom, the United States, and Europe. It develops SkinBiotix technology that promotes skin health by harnessing the beneficial properties of probiotic bacteria and the active components; and AxisBiotix technology that focuses on the gut-skin relationship and is designed to alleviate the symptoms associated with psoriasis.
Featured Stories
- Five stocks we like better than SkinBioTherapeutics
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Qualcomm Stock: AI-Powered Growth Despite Volatility
- Profitably Trade Stocks at 52-Week Highs
- Salesforce Stock: Meeting Recap, AI Focus, and Forecast
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Is CAVA Overextended? A Closer Look at This High-Flying Stock
Receive News & Ratings for SkinBioTherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SkinBioTherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
